Vanguard Group’s CureVac CVAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
96,051
+24,283
| +34% | +$131K | ﹤0.01% | 3911 |
|
|
2025
Q1 | $200K | Hold |
71,768
| – | – | ﹤0.01% | 4077 |
|
|
2024
Q4 | $224K | Hold |
71,768
| – | – | ﹤0.01% | 4083 |
|
|
2024
Q3 | $221K | Sell |
71,768
-65,051
| -48% | -$200K | ﹤0.01% | 4121 |
|
|
2024
Q2 | $465K | Buy |
136,819
+11,493
| +9% | +$39.1K | ﹤0.01% | 4030 |
|
|
2024
Q1 | $380K | Buy |
125,326
+18
| +0% | +$55 | ﹤0.01% | 4074 |
|
|
2023
Q4 | $528K | Hold |
125,308
| – | – | ﹤0.01% | 4017 |
|
|
2023
Q3 | $856K | Buy |
125,308
+4,038
| +3% | +$27.6K | ﹤0.01% | 3891 |
|
|
2023
Q2 | $1.26M | Buy |
121,270
+31,196
| +35% | +$325K | ﹤0.01% | 3826 |
|
|
2023
Q1 | $628K | Buy |
90,074
+15,991
| +22% | +$111K | ﹤0.01% | 4054 |
|
|
2022
Q4 | $447K | Buy |
74,083
+1,300
| +2% | +$7.84K | ﹤0.01% | 4124 |
|
|
2022
Q3 | $574K | Buy |
72,783
+22
| +0% | +$174 | ﹤0.01% | 4176 |
|
|
2022
Q2 | $990K | Sell |
72,761
-24,566
| -25% | -$334K | ﹤0.01% | 4094 |
|
|
2022
Q1 | $1.91M | Sell |
97,327
-6,563
| -6% | -$129K | ﹤0.01% | 3976 |
|
|
2021
Q4 | $3.56M | Buy |
103,890
+10,675
| +11% | +$366K | ﹤0.01% | 3795 |
|
|
2021
Q3 | $5.09M | Buy |
93,215
+10,847
| +13% | +$592K | ﹤0.01% | 3649 |
|
|
2021
Q2 | $6.05M | Buy |
82,368
+44,944
| +120% | +$3.3M | ﹤0.01% | 3491 |
|
|
2021
Q1 | $3.42M | Buy |
+37,424
| New | +$3.42M | ﹤0.01% | 3707 |
|